CR9651A - Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis - Google Patents
Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesisInfo
- Publication number
- CR9651A CR9651A CR9651A CR9651A CR9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A CR 9651 A CR9651 A CR 9651A
- Authority
- CR
- Costa Rica
- Prior art keywords
- synthesis
- alquilquinolina
- alqilquinazolina
- cinasa
- modulators
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 2
- 238000003786 synthesis reaction Methods 0.000 title 2
- 239000000543 intermediate Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68938405P | 2005-06-10 | 2005-06-10 | |
| US73091905P | 2005-10-27 | 2005-10-27 | |
| US78955106P | 2006-04-05 | 2006-04-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR9651A true CR9651A (es) | 2008-09-09 |
Family
ID=37038264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR9651A CR9651A (es) | 2005-06-10 | 2008-01-09 | Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7825244B2 (es) |
| EP (1) | EP1891040A1 (es) |
| JP (1) | JP2008545787A (es) |
| KR (1) | KR20080033234A (es) |
| AR (1) | AR054387A1 (es) |
| AU (1) | AU2006258056A1 (es) |
| BR (1) | BRPI0612543A2 (es) |
| CA (1) | CA2611219A1 (es) |
| CR (1) | CR9651A (es) |
| EA (1) | EA200800010A1 (es) |
| EC (1) | ECSP077993A (es) |
| GT (1) | GT200600250A (es) |
| IL (1) | IL187688A0 (es) |
| MX (1) | MX2007015739A (es) |
| NI (1) | NI200700312A (es) |
| NO (1) | NO20080160L (es) |
| PA (1) | PA8679201A1 (es) |
| TW (1) | TW200718694A (es) |
| UY (1) | UY29589A1 (es) |
| WO (1) | WO2006135646A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8071768B2 (en) | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
| US7825244B2 (en) | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| US8880138B2 (en) * | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
| KR101744033B1 (ko) * | 2013-10-16 | 2017-06-07 | 후지필름 가부시키가이샤 | 함질소 복소환 화합물의 염 또는 그 결정, 의약 조성물 및 flt3 저해제 |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3517005A (en) | 1967-10-26 | 1970-06-23 | Pfizer & Co C | Certain 2- and 4-substituted quinazolines |
| GB1460389A (en) | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| JPS5976082A (ja) | 1982-10-23 | 1984-04-28 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
| GB8320958D0 (en) | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| US5300515A (en) | 1991-01-31 | 1994-04-05 | Kyorin Pharmaceutical Co., Ltd. | Carbamic acid derivatives and method for preparing the same |
| PT627940E (pt) | 1992-03-05 | 2003-07-31 | Univ Texas | Utilizacao de imunoconjugados para o diagnostico e/ou terapia de tumores vascularizados |
| US5474765A (en) | 1992-03-23 | 1995-12-12 | Ut Sw Medical Ctr At Dallas | Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells |
| GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
| GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
| JPH10506560A (ja) | 1995-04-19 | 1998-06-30 | シュナイダー（ユーエスエー）インク | 薬品を放出する被覆されたステント |
| WO1997028118A1 (en) | 1996-02-05 | 1997-08-07 | Hoechst Celanese Corporation | Process for preparing anthranilic acids |
| JP2001511764A (ja) | 1996-04-12 | 2001-08-14 | 住友製薬株式会社 | ピペリジニルピリミジン誘導体 |
| US5948786A (en) | 1996-04-12 | 1999-09-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyrimidine derivatives |
| EP0882717B1 (en) | 1996-10-01 | 2010-09-08 | Kyowa Hakko Kirin Co., Ltd. | Nitrogenous heterocyclic compounds |
| US5866562A (en) | 1996-10-25 | 1999-02-02 | Bayer Aktiengesellschaft | Ring-bridged bis-quinolines |
| CA2313125A1 (en) | 1997-12-12 | 1999-06-24 | Laramie Mary Gaster | Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
| DE19756388A1 (de) | 1997-12-18 | 1999-06-24 | Hoechst Marion Roussel De Gmbh | Substituierte 2-Aryl-4-amino-chinazoline |
| GB9819382D0 (en) | 1998-09-04 | 1998-10-28 | Cerebrus Ltd | Chemical compounds I |
| US6342219B1 (en) | 1999-04-28 | 2002-01-29 | Board Of Regents, The University Of Texas System | Antibody compositions for selectively inhibiting VEGF |
| SV2002000205A (es) | 1999-11-01 | 2002-06-07 | Lilly Co Eli | Compuestos farmaceuticos ref. x-01095 |
| US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
| EP1309567A2 (en) | 2000-08-18 | 2003-05-14 | Millennium Pharmaceuticals, Inc. | Nitrogenous heterocyclic compounds |
| DE60143204D1 (de) | 2000-08-18 | 2010-11-18 | Kyowa Hakko Kirin Co Ltd | N-aryl-ä4-Ä7-(alkoxy)Chinazolin-4-ylÜPiperazinylüCarboxamid-Verbindungen als PDGF-Rezeptoren Hemmer |
| ATE303998T1 (de) | 2000-10-17 | 2005-09-15 | Merck & Co Inc | Oral aktive salze mit tyrosinkinaseaktivität |
| EP1347982B1 (en) | 2000-12-12 | 2005-11-16 | Neurogen Corporation | Spiro isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines |
| DE10109866A1 (de) | 2001-03-01 | 2002-09-05 | Abbott Gmbh & Co Kg | Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie |
| US7074801B1 (en) | 2001-04-26 | 2006-07-11 | Eisai Co., Ltd. | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| TWI238824B (en) | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
| WO2003024969A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| WO2003024931A1 (en) | 2001-09-14 | 2003-03-27 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
| TWI259081B (en) | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
| DE60213842T2 (de) | 2001-10-30 | 2007-09-06 | Novartis Ag | Staurosporin-derivate als hemmer der flt3-rezeptor-tyrosinkinase-wirkung |
| EP1458713B1 (en) | 2001-12-27 | 2005-08-24 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
| SI1474420T1 (sl) | 2002-02-01 | 2012-06-29 | Astrazeneca Ab | Spojine kinazolina |
| PE20040522A1 (es) | 2002-05-29 | 2004-09-28 | Novartis Ag | Derivados de diarilurea dependientes de la cinasa de proteina |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| BR0312204A (pt) | 2002-06-27 | 2005-04-26 | Schering Ag | Antagonista de receptor ccr5 de quinolina substituìda |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| AU2003262642B2 (en) | 2002-08-14 | 2010-06-17 | Vertex Pharmaceuticals Incorporated | Protein kinase inhibitors and uses thereof |
| EP1539754A4 (en) | 2002-08-23 | 2009-02-25 | Novartis Vaccines & Diagnostic | BENZIMIDAZOCHINOLINONE AND ITS USE |
| EP1566379A4 (en) | 2002-10-29 | 2005-11-09 | Kirin Brewery | CHINOLINE DERIVATIVES AND CHINAZOLINE DERIVATIVES AS INHIBITORS OF FLT3 AUTOPHOSPHORYLATION AND THE MEDICAL COMPOSITIONS CONTAINING THEREOF |
| SG148864A1 (en) | 2002-11-13 | 2009-01-29 | Chiron Corp | Methods of treating cancer and related methods |
| TWI335913B (en) | 2002-11-15 | 2011-01-11 | Vertex Pharma | Diaminotriazoles useful as inhibitors of protein kinases |
| DE60326646D1 (de) | 2002-12-18 | 2009-04-23 | Vertex Pharma | Benzisoxazolderivate, die sich als inhibitoren von proteinkinasen eigen |
| WO2004058727A1 (en) | 2002-12-20 | 2004-07-15 | Bayer Pharmaceuticals Corporation | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
| TW200508224A (en) | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| JP4845736B2 (ja) | 2003-10-14 | 2011-12-28 | アリゾナ ボード オブ リージェンツ オン ビハーフ ザ ユニバーシティー オブ アリゾナ | プロテインキナーゼ阻害剤 |
| NZ590160A (en) | 2003-11-21 | 2012-07-27 | Array Biopharma Inc | AKT protein kinase inhibitors |
| US7825244B2 (en) | 2005-06-10 | 2010-11-02 | Janssen Pharmaceutica Nv | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis |
| US8071768B2 (en) * | 2005-06-10 | 2011-12-06 | Janssen Pharmaceutica, N.V. | Alkylquinoline and alkylquinazoline kinase modulators |
-
2006
- 2006-06-06 US US11/422,352 patent/US7825244B2/en active Active
- 2006-06-07 EP EP06760725A patent/EP1891040A1/en not_active Withdrawn
- 2006-06-07 BR BRPI0612543-3A patent/BRPI0612543A2/pt not_active IP Right Cessation
- 2006-06-07 MX MX2007015739A patent/MX2007015739A/es unknown
- 2006-06-07 KR KR1020087000200A patent/KR20080033234A/ko not_active Withdrawn
- 2006-06-07 JP JP2008515888A patent/JP2008545787A/ja not_active Withdrawn
- 2006-06-07 AU AU2006258056A patent/AU2006258056A1/en not_active Abandoned
- 2006-06-07 EA EA200800010A patent/EA200800010A1/ru unknown
- 2006-06-07 CA CA002611219A patent/CA2611219A1/en not_active Abandoned
- 2006-06-07 WO PCT/US2006/022171 patent/WO2006135646A1/en not_active Ceased
- 2006-06-08 GT GT200600250A patent/GT200600250A/es unknown
- 2006-06-08 PA PA20068679201A patent/PA8679201A1/es unknown
- 2006-06-08 UY UY29589A patent/UY29589A1/es unknown
- 2006-06-09 AR ARP060102423A patent/AR054387A1/es not_active Application Discontinuation
- 2006-06-09 TW TW095120478A patent/TW200718694A/zh unknown
-
2007
- 2007-11-27 IL IL187688A patent/IL187688A0/en unknown
- 2007-11-29 NI NI200700312A patent/NI200700312A/es unknown
- 2007-12-10 EC EC2007007993A patent/ECSP077993A/es unknown
-
2008
- 2008-01-09 CR CR9651A patent/CR9651A/es not_active Application Discontinuation
- 2008-01-09 NO NO20080160A patent/NO20080160L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070021436A1 (en) | 2007-01-25 |
| GT200600250A (es) | 2007-03-14 |
| IL187688A0 (en) | 2008-08-07 |
| JP2008545787A (ja) | 2008-12-18 |
| MX2007015739A (es) | 2008-04-29 |
| EP1891040A1 (en) | 2008-02-27 |
| KR20080033234A (ko) | 2008-04-16 |
| BRPI0612543A2 (pt) | 2010-11-23 |
| TW200718694A (en) | 2007-05-16 |
| US7825244B2 (en) | 2010-11-02 |
| UY29589A1 (es) | 2006-10-02 |
| ECSP077993A (es) | 2008-01-23 |
| PA8679201A1 (es) | 2007-01-17 |
| CA2611219A1 (en) | 2006-12-21 |
| AU2006258056A1 (en) | 2006-12-21 |
| NI200700312A (es) | 2009-02-19 |
| EA200800010A1 (ru) | 2008-06-30 |
| AR054387A1 (es) | 2007-06-20 |
| NO20080160L (no) | 2008-01-09 |
| WO2006135646A1 (en) | 2006-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1920065T (pt) | Anticorpos anti-alfavbeta6 e suas utilizações | |
| DK1934179T3 (da) | Fremgangsmåder og mellemprodukter | |
| EP1857091A4 (en) | COSMETIC | |
| CY2013046I2 (el) | Καινοτομος χρηση των αντισωματων αντι il-1bhta | |
| EP1883519A4 (en) | HYDROGEL CONSTRUCTS MANUFACTURED BY STEREOLITHOGRAPHY | |
| HRP20220755T3 (hr) | Anti-gm-csf antitijela i njihova uporaba | |
| EP2023656A4 (en) | ACOUSTIC EXTRACTION DEVICE AND LOUDSPEAKER THEREFOR | |
| IL187303A0 (en) | Methods of prepering 3 - cyano - quinolines and intermediates made thereby | |
| BRPI0909954A2 (pt) | "diazacarbazóis e métodos de uso" | |
| EP1841794A4 (en) | MODULATORS ADAM-9 | |
| DE602005022364D1 (de) | Selbstbräunendes kosmetikum | |
| DE602006018166D1 (de) | Polyrotaxanhaltige lösung und verwendung davon | |
| DE602006003063D1 (de) | Tripeptid- und tetrapeptidsulfone | |
| CR9651A (es) | Intermedios utiles en la sintesis de moduladores de alquilquinolina y alqilquinazolina cinasa y metodos relacionados de sintesis | |
| PT1763520E (pt) | Utilização de benzopiranonas trissubstituídas | |
| EP1915162A4 (en) | Modulators | |
| DK1736159T3 (da) | Hudplejemiddel | |
| EP1910272A4 (en) | Renin Inhibitors | |
| EP1722013A4 (en) | GALVANIZATION IN THE PRESENCE OF CO2 | |
| FR2877833B1 (fr) | Correcteur de lordoses | |
| FR2887144B3 (fr) | Audio vibromasseur | |
| EP1942012A4 (en) | COVER FIXING DEVICE | |
| ZA200800276B (en) | Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators and related methods of synthesis | |
| ES1061722Y (es) | Pavimento desmontable | |
| DE602005002738D1 (de) | Syntheseverfahren und benzoxathiepinzwischenprodukte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |